Mumbai, India , is rapidly emerging as a significant hub for the production of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established robust manufacturing facilities focusing on this critical antiviral compound. Identifying the precise top manufacturers can be challenging due to fluctuating market dynamics, but reputable names of